‘Magic Mushroom’ Company Goes Mainstream, Jumps 71% Post-IPO

(Bloomberg) -- Compass Pathways Plc, the U.K. company that has patented a synthetic version of the active ingredient in so-called magic mushrooms for use in treatment-resistant depression, went pub...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.